Here are five points:
1. Mr. Lucera will take over as CFO on Aug. 29.
2. He will work out of the company’s Shrewsbury, Mass., office.
3. Mr. Lucera will oversee the Valeritas’ capital-efficient commercial strategy.
4. He has more than 20 years of experience in biotechnology, specialty pharmaceutical and medical technology companies.
5. Mr. Lucera previously served as CFO of Canada-based Viventia Bio.
More articles on quality & infection control:
Antibiotic-resistant infections cost $20B annually & 5 more statistics
AmSurg centers participate in ASC Quality Measures
Study: Viruses striking in the morning are 10x more successful in infecting
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.